World's Best Scientists 2026 revealed!
Fumitaka Suzuki

Fumitaka Suzuki

Award Badge
Microbiology
Taiwan
2025

D-Index & Metrics

Microbiology

D-Index
73
Citations
17991
World Ranking
1675
National Ranking
45

Medicine

D-Index
74
Citations
19088
World Ranking
19432
National Ranking
624

Research.com Recognitions

  • 2025 - Research.com Microbiology in Taiwan Leader Award
  • 2022 - Research.com Microbiology in Taiwan Leader Award

Overview

Fumitaka Suzuki is affiliated with National Taiwan University in Taiwan and has an extensive publication record predominantly within the field of Medicine. Their research primarily focuses on hepatology, epidemiology, and oncology, with a considerable portion of studies related to liver disease diagnosis and treatment, hepatocellular carcinoma, and viral hepatitis.

Their recent significant papers include:

  • Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular Carcinoma, 2020, Liver Cancer
  • Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy, 2022, Journal of Hepatology
  • SGLT2 Inhibitor Treatment Outcome in Nonalcoholic Fatty Liver Disease Complicated with Diabetes Mellitus: The Long-term Effects on Clinical Features and Liver Histopathology, 2020, Internal Medicine
  • Pretreatment Heterogeneous Enhancement Pattern of Hepatocellular Carcinoma May Be a Useful New Predictor of Early Response to Lenvatinib and Overall Prognosis, 2020, Liver Cancer
  • Favorable impact of long-term SGLT2 inhibitor for NAFLD complicated by diabetes mellitus: A 5-year follow-up study, 2022, Hepatology Communications

Fumitaka Suzuki frequently collaborates with multiple coauthors, including:

  • Hiromitsu Kumada
  • Tetsuya Hosaka
  • Yusuke Kawamura
  • Norio Akuta
  • Yoshiyuki Suzuki

The scientist's work is regularly published in specific venues, reflecting their research scope. These publication venues include:

  • Hepatology Research
  • Oncology
  • Internal Medicine
  • Clinical Journal of Gastroenterology
  • Journal of Hepatology

Within the broader field of Medicine, Suzuki has contributed extensively to subfields as outlined below:

  • Hepatology
  • Epidemiology
  • Oncology
  • Pulmonary and Respiratory Medicine
  • Surgery

Key research topics addressed by Suzuki focus on the following areas:

  • Liver Disease Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatitis B Virus Studies
  • Hepatitis C virus research
  • Liver Disease and Transplantation
  • Diet, Metabolism, and Disease
  • MRI in cancer diagnosis

Best Publications

  • Long‐term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

    Tetsuya Hosaka;Fumitaka Suzuki;Masahiro Kobayashi;Yuya Seko

  • Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor—A prospective randomized study of hepatitis C virus–related liver cancer

    Kenji Ikeda;Yasuji Arase;Satoshi Saitoh;Masahiro Kobayashi

  • Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels

    Norio Akuta;Fumitaka Suzuki;Yusuke Kawamura;Hiromi Yatsuji

  • Association of Amino Acid Substitution Pattern in Core Protein of Hepatitis C Virus Genotype 1b High Viral Load and Non-Virological Response to Interferon-Ribavirin Combination Therapy

    Norio Akuta;Fumitaka Suzuki;Hitomi Sezaki;Yoshiyuki Suzuki

  • Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin

    Norio Akuta;Fumitaka Suzuki;Miharu Hirakawa;Yusuke Kawamura

  • Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C

    Yasuji Arase;Fumitaka Suzuki;Yoshiyuki Suzuki;Norio Akuta

  • Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma.

    Yusuke Kawamura;Yasuji Arase;Kenji Ikeda;Yuya Seko

  • Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options.

    Yoshiyuki Suzuki;Kenji Ikeda;Fumitaka Suzuki;Joji Toyota

  • Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis

    Yee Hui Yeo;Hsiu J. Ho;Hwai I. Yang;Tai Chung Tseng

  • Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus–related cirrhosis

    Unknown

  • Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C.

    Yasuji Arase;Mariko Kobayashi;Fumitaka Suzuki;Yoshiyuki Suzuki

  • Correlation between serum hepatitis B virus core‐related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients

    Fumitaka Suzuki;Hideo Miyakoshi;Mariko Kobayashi;Hiromitsu Kumada

  • Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir.

    Yoshiyasu Karino;Joji Toyota;Kenji Ikeda;Fumitaka Suzuki

  • Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patients

    Atsushi Ono;Fumitaka Suzuki;Yusuke Kawamura;Hitomi Sezaki

  • Randomized phase 3 trial of ombitasvir/paritaprevir/ritonavir for hepatitis C virus genotype 1b-infected Japanese patients with or without cirrhosis.

    Hiromitsu Kumada;Kazuaki Chayama;Lino Rodrigues;Fumitaka Suzuki

  • Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis

    Tsunehisa Kawasaki;Akihiro Takeshita;Kenichi Souda;Yoshimasa Kobayashi

  • Long-Term Outcome after Hepatitis B Surface Antigen Seroclearance in Patients with Chronic Hepatitis B

    Yasuji Arase;Kenji Ikeda;Fumitaka Suzuki;Yoshiyuki Suzuki

  • Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C

    Yusuke Kawamura;Kenji Ikeda;Yasuji Arase;Hiromi Yatsuji

  • Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan.

    Yoshiyuki Suzuki;Mariko Kobayashi;Kenji Ikeda;Fumitaka Suzuki

  • Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis.

    Norio Akuta;Fumitaka Suzuki;Yusuke Kawamura;Hiromi Yatsuji

  • IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis C

    Kazuaki Chayama;C. Nelson Hayes;Hiromi Abe;Daiki Miki

  • The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment

    Norio Akuta;Fumitaka Suzuki;Mariko Kobayashi;Akihito Tsubota

Frequent Co-Authors

Hiromitsu Kumada
Hiromitsu Kumada Fukuoka University
Kenji Ikeda
Kenji Ikeda University of California, San Francisco
Yoshiyuki Suzuki
Yoshiyuki Suzuki Fukushima Medical University
Yasuji Arase
Yasuji Arase University of Yamanashi
Masahiro Kobayashi
Masahiro Kobayashi Toranomon Hospital
Tetsuya Hosaka
Tetsuya Hosaka Toranomon Hospital
Hitomi Sezaki
Hitomi Sezaki Toranomon Hospital
Satoshi Saitoh
Satoshi Saitoh Toranomon Hospital
Mariko Kobayashi
Mariko Kobayashi Kaohsiung Medical University
Kazuaki Chayama
Kazuaki Chayama Hiroshima University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online degrees can open up a variety of career opportunities. Many aspiring healthcare professionals consider medical programs online, which offer flexible learning paths while maintaining rigorous standards. These programs often serve as a foundation for specialized scientific and clinical roles.

Public health is another closely related field, with numerous institutions offering some of the best easiest mph online programs to get into. Pursuing a Master of Public Health (MPH) complements microbiology by focusing on disease prevention, epidemiology, and community health initiatives.

For those interested in therapeutic and support roles, becoming certified as a Child Life Specialist is a rewarding pathway. Learning more about ccls certification can guide microbiology graduates toward careers in child-focused healthcare settings.

Importantly, online education has become more accessible for diverse populations, including those with previous convictions. Resources highlighting online degrees for felons emphasize inclusive opportunities that help many students pursue science and health-related careers without barriers.

Best Scientists Citing Fumitaka Suzuki

Trending Scientists

Recently Published Articles